Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Healthpeak Properties (DOC)

Healthpeak Q1 net income rises to $0.06 per share from $0.01; 2025 guidance reaffirmed

Positive Impact 3 of 5 earnings Written later

Healthpeak reported first quarter 2025 results, with net income applicable to common shares of $42.4 million, or $0.06 per diluted share, up from $6.5 million, or $0.01, a year earlier. Diluted Nareit FFO rose to $0.45 per share from $0.27, and the company reaffirmed its full-year 2025 guidance, including diluted earnings per share of $0.30 to $0.36.

Key points

  • Q1 2025 diluted net income of $0.06 per share versus $0.01 in Q1 2024; diluted Nareit FFO of $0.45 versus $0.27
  • Diluted FFO as Adjusted of $0.46 per share versus $0.45; diluted AFFO of $0.43 versus $0.42
  • 2025 guidance reaffirmed: diluted EPS of $0.30 to $0.36 and diluted Nareit FFO of $1.81 to $1.87 per share; monthly dividend of $0.10167 per share for April, May and June

The filing

CompanyHealthpeak Properties (DOC)
Form8-K, current report
Filed with the SECApr 24, 2025, 4:19 PM ET
Accession number0001628280-25-019678

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.